Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1231 AL 1245

The nonmotor features of Parkinson's disease: pathophysiology and management advances

Reichmann H, Brandt MD, Klingelhoefer L.

Curr Opin Neurol. 2016 Aug;29(4):467-73. doi: 10.1097/WCO.0000000000000348.

Pimavanserin: First Global Approval

Markham A.

Drugs. 2016 Jul;76(10):1053-7. doi: 10.1007/s40265-016-0597-9.

Paraneoplastic Atypical Parkinsonism with Anti-CRMP5 Antibodies and Severe Caudate and Putaminal Hypometabolism on 18-Fluorodeoxyglucose Positron Emission Tomography of the Brain

Yap SM, Lynch T, MacMahon P, Murray B.

Mov Disord Clin Pract. 2016 Jun 6;4(2):263-265. doi: 10.1002/mdc3.12370. eCollection 2017 Mar-Apr.

[Parkinson's disease and nucleolar stress]

Zhou Q, Chen Y, Wei Q, Shang H.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Jun;33(3):392-5. doi: 10.3760/cma.j.issn.1003-9406.2016.03.026.

Neurologic Diseases in Special Care Patients

Robbins MR.

Dent Clin North Am. 2016 Jul;60(3):707-35. doi: 10.1016/j.cden.2016.03.002.

Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

Batla A, Phé V, De Min L, Panicker JN.

Mov Disord Clin Pract. 2016 Jun 7;3(5):443-451. doi: 10.1002/mdc3.12374. eCollection 2016 Sep-Oct.

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease

Hauser RA, Slawek J, Barone P, Dohin E, Surmann E, Asgharnejad M, Bauer L.

BMC Neurol. 2016 Jun 7;16:90. doi: 10.1186/s12883-016-0610-7.

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)

Singh NA, Mandal AK, Khan ZA.

Nutr J. 2016 Jun 7;15(1):60. doi: 10.1186/s12937-016-0179-4.

Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease

Tard C, Devanne H, Defebvre L, Delval A.

Neurosci Lett. 2016 Aug 15;628:1-9. doi: 10.1016/j.neulet.2016.05.061. Epub 2016 Jun 3.

Mutational scanning of the CHCHD2 gene in Han Chinese patients with Parkinson's disease and meta-analysis of the literature

Yang X, Zhao Q, An R, Zheng J, Tian S, Chen Y, Xu Y.

Parkinsonism Relat Disord. 2016 Aug;29:42-6. doi: 10.1016/j.parkreldis.2016.05.032. Epub 2016 May 30.

Association of leptin with orthostatic blood pressure changes in Parkinson's disease

Nakamura T, Suzuki M, Okada A, Suzuki J, Hasegawa S, Koike H, Hirayama M, Katsuno M, Sobue G.

Mov Disord. 2016 Sep;31(9):1417-21. doi: 10.1002/mds.26678. Epub 2016 Jun 6.

[Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures]

Grander W.

Med Klin Intensivmed Notfmed. 2016 Jun;111(5):407-16. doi: 10.1007/s00063-016-0173-9. Epub 2016 Jun 7.

Continuous dopaminergic stimulation therapy for Parkinson's disease - recent advances

Timpka J, Mundt-Petersen U, Odin P.

Curr Opin Neurol. 2016 Aug;29(4):474-9. doi: 10.1097/WCO.0000000000000354.

Atypical parkinsonism - new advances

Stamelou M, Bhatia KP.

Curr Opin Neurol. 2016 Aug;29(4):480-5. doi: 10.1097/WCO.0000000000000355.

Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation

McIntyre CC, Anderson RW.

J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):338-345. doi: 10.1111/jnc.13649. Epub 2016 Jun 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias